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Here, we investigated the role of the Wnt/β-catenin signaling pathway in chicken primordial germ cells 
(PGCs) in vitro. We confirmed the expression of Wnt signaling pathway-related genes and the localization 
of β-catenin in the nucleus, revealing that this pathway is potentially activated in chicken PGCs. Then, 
using the single-cell pick-up assay, we examined the proliferative capacity of cultured PGCs in response 
to Wnt ligands, a β-catenin-mediated Wnt signaling activator (6-bromoindirubin-3′-oxime [BIO]) or 
inhibitor (JW74), in the presence or absence of basic fibroblast growth factor (bFGF). WNT1, WNT3A, 
and BIO promoted the proliferation of chicken PGCs similarly to bFGF, whereas JW74 inhibited this 
proliferation. Meanwhile, such treatments in combination with bFGF did not show a synergistic effect. 
bFGF treatment could not rescue PGC proliferation in the presence of JW74. In addition, we confirmed 
the translocation of β-catenin into the nucleus by the addition of bFGF after JW74 treatment. These 
results indicate that there is signaling crosstalk between FGF and Wnt, and that β-catenin acts on PGC 
proliferation downstream of bFGF. In conclusion, our study suggests that Wnt signaling enhances the 
proliferation of chicken PGCs via the stabilization of β-catenin and activation of its downstream genes.
Primordial germ cells (PGCs), the precursors of sperm or oocytes, undergo numerous spatially and temporally 
specific regulatory pathways during early development1. It has been revealed that these complex regulatory net-
works in PGCs are governed by several extrinsic factors leading to intracellular pathways2. Although the molec-
ular mechanisms underlying signal transduction in PGCs remain poorly defined, leukemia inhibitory factor, 
basic fibroblast growth factor (bFGF), bone morphogenetic protein 4, and kit ligand are the best studied signaling 
pathways known to control PGC survival and proliferation3.
Previously, several studies reported a list of PGC specific genes by transcriptome analysis containing 
Wnt/β -catenin signaling-related genes4,5. Also, while we were searching for target genes regulated by micro RNA 
(miRNA) specifically expressed in PGCs based on the previous result6, we found that several negative regulators 
for Wnt signaling pathway, such as Glycogen synthase kinase-3-β (GSK3β ), APC, and AXIN, might be target for 
those miRNAs, indicating possible role of Wnt pathway in chicken PGCs.
The Wnt pathway is a well-known signaling cascade that is involved in PGC development including specifi-
cation, migration, and proliferation7–10. The Wnt/β -catenin pathway, or so-called canonical Wnt signaling, main-
tains embryonic stem (ES) cells in an undifferentiated state and promotes proliferative capacity in both stem 
cells and cancer cells11,12. β -catenin is a key mediator of canonical Wnt signaling, and acts as a transcriptional 
co-activator to control the expression of cell cycle-related genes13,14. The importance of Wnt/β -catenin signaling 
in the proliferation of PGCs has been reported in mice and Drosophila8,15,16, but not in chickens.
Several inhibitors, such as 6-bromoindirubin-3′ -oxime (BIO) and JW74, have been utilized to activate or 
block such signaling. BIO, an inhibitor of the negative regulator GSK3β , leads to target gene expression by stabi-
lizing β -catenin from the degradation complex11,17, whereas JW74 stabilizes AXIN, a component of the β -catenin 
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degradation complex, eventually causing β -catenin degradation18. Accordingly, BIO and JW74 were used in this 
study to modulate the level of β -catenin in chicken PGCs in vitro.
Another growth factor family involved in cell proliferation, migration, and differentiation during embryonic 
development is bFGF, also known as FGF219,20. bFGF is a powerful mitogen in PGC culture in mammals21 and 
supports the proliferation of embryonic germ cells22 and PGCs in chickens23. Choi et al.24 and Macdonald et al.25 
identified bFGF as an essential factor for in vitro PGC proliferation24,25. Among several downstream cascades of 
bFGF, including the PI3K/AKT and MEK/ERK pathways, chicken PGCs mediate MEK/ERK signaling for pro-
liferation24. Recently, Whyte et al.26 reported that three different signals, such as TGF beta, FGF, and Insulin are 
required for PGC proliferation in chicken, suggesting presence of combinatorial action of several signaling path-
ways26. Meanwhile, numerous recent studies have demonstrated the crosstalk between FGF and Wnt/β -catenin 
signaling. For example, β -catenin is activated by FGF signaling through the RAS/ERK or PI3K/AKT cascade, 
and acts downstream of these pathways in several stem cells or progenitor cells27–30. In addition, FGF can activate 
Wnt signaling by phosphorylation of the Wnt co-receptor LRP631,32 or inactivation of the Wnt inhibitor Dkk133.
In this study, the expression of Wnt/β -catenin signaling-related genes was examined to determine whether 
PGCs are capable of activating this signaling pathway. BIO and JW74 were applied to modulate Wnt/β -catenin 
signaling in cultured chicken PGCs. Subsequently, an in vitro proliferation assay was performed in the presence of 
a Wnt ligand, BIO, JW74, or bFGF to verify the signaling mechanism underlying PGC proliferation in chickens. 
Lastly, to verify the crosstalk between bFGF and Wnt/β -catenin signaling in PGC proliferation, Western blotting 
and immunocytochemistry were used to examine the translocation of β -catenin into the nucleus, which was 
stimulated by bFGF after JW74 treatment.
Results
Expression of Wnt signaling-related genes in chicken PGCs. To examine whether chicken PGCs 
have the ability to process Wnt/β -catenin signaling, RT-PCR was performed to analyze several components of 
this pathway. Among the many Wnt ligands and receptors, there was confirmed expression of WNT1, WNT3A, 
and WNT9B, which are well-known proteins in the canonical Wnt pathway; Frizzled receptors 1 and 3, which 
interact with WNT3A34,35; and LRP5 and 6, which are co-receptors of canonical Wnt signaling36–38 (Fig. 1A). In 
light of these findings, Wnt ligands and their receptors were well expressed in both gonadal and cultured PGCs 
(SNUhp26), and other key factors such as β-catenin, GSK3β , and TCFs (except for TCF3) were also expressed in 
gonadal stromal cells and chicken embryonic fibroblasts as well as gonadal PGCs and cultured PGCs, indicating 
that chicken PGCs might be capable of activating Wnt/β -catenin signaling (Fig. 1A). In particular, most Wnt sign-
aling pathway-related genes, such as all three Wnt ligands, FZDs, LRPs, TCFs, and LEF1, were highly expressed in 
cultured PGCs compared to those in gonadal PGCs. To determine the status of β -catenin in PGCs, cultured PGCs 
were subjected to immunostaining (Fig. 1B). The results showed that β -catenin was localized in both the nucleus 
and cytoplasm, indicating that it is stabilized in cultured PGCs.
Figure 1. Expression of Wnt signaling pathway-related genes in cultured chicken primordial germ cells 
(PGCs). (A) The expression of Wnt signaling pathway-related genes including WNT1, WNT3A, WNT9B, 
FZD1, FZD3, LRP5, LRP6, β-catenin, GSK3β , TCF1, LEF1, TCF3, and TCF4 and germ cell-related genes 
including DAZL and VASA was analyzed using reverse transcription polymerase chain reaction (RT-PCR) in 
gonadal PGCs and gonadal stromal cells (GSCs), which were separated from day 6 embryonic gonads, chicken 
embryonic fibroblasts (CEFs), and a cultured chicken PGC line, SNUhp26. Most of the Wnt signaling pathway-
related genes were upregulated in SNUhp26 compared to those in gonadal PGCs. (B) Immunostaining showed 
the localization of β -catenin in both the nucleus and cytoplasm in cultured chicken PGCs.
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Verification of the role of Wnt/β-catenin signaling in chicken PGCs via BIO and JW74. In several 
types of cells, such as cancer cells and ES cells, BIO and JW74 have been used for modulating β -catenin as an 
activator and an inhibitor, respectively17,18,39. To test whether β -catenin also works in cultured chicken PGCs, BIO 
and JW74 were administered at different concentrations for 3 and 5 days (Fig. 2A). Their effects were detected by 
Western blotting with the antibody for active β -catenin (ABC), which is the non-phosphorylated form (Fig. 2A). 
Among the various conditions, 1 μ M BIO showed optimal effect of Wnt signaling activation in cultured chicken 
PGCs when it was applied for 3 rather than 5 days (Fig. 2B). In the case of JW74, the levels of ABC protein gradu-
ally decreased in a dose-dependent manner. However, the level of β -actin also decreased when JW74 was applied 
at a concentration greater than 10 μ M, meaning that it was toxic to chicken PGCs (Fig. 2A). Thus, 1 μ M BIO and 
10 μ M JW74 were used for subsequent experiments in this study (Fig. 2B).
To clarify the importance of Wnt/β -catenin signaling in PGCs, loss-of-function studies were conducted by 
treating cultured PGCs with JW74. JW74 treatment caused the degradation of β -catenin in both the nucleus 
and cytoplasm, indicating that Wnt signaling had been inactivated (Fig. 2C). JW74 treatment also caused the 
downregulation of cell cycle-related genes essential for entry in G1 phase, such as CCND1 and CDK6, and germ 
cell-specific genes, such as cDAZL and CVH, while no effect on cell cycle-related genes regulating progression 
from G1 to S phase, such as CCNE1 and CDK2 (Fig. 2D).
Proliferation assay of chicken PGCs with Wnt ligand, BIO or JW74. To investigate whether 
Wnt/β -catenin is involved in PGC proliferation in vitro and related to bFGF signaling in chicken PGCs, a Wnt 
ligand (WNT1, WNT3A, and WNT9B), BIO or JW74, were applied at different concentrations, after which a cell 
proliferation assay was performed (Fig. 3). To simplify determination of the cell number, SNUhp26 male chicken 
PGCs expressing GFP were used. After bFGF starvation for 4 days to remove all of the effects of bFGF signaling, 
a single PGC was added to a culture under each set of conditions. Then, the number of PGCs was counted on day 
Figure 2. Regulation of β-catenin signaling by 6-bromoindirubin-3′-oxime (BIO) or JW74 treatment for 
optimization of chicken PGCs (SNUhp26) in vitro. (A) The level of active β -catenin (ABC) changed after 
BIO or JW74 treatment in a dose-dependent manner, as determined by Western blotting. (B) BIO applied at 
1 μ M and JW74 at 10 μ M for 3 days showed optimal effects to increase or decrease the β -catenin level. BIO, a 
GSK3β inhibitor; JW74, a β -catenin inhibitor. (C) Immunostaining showed that JW74 treatment caused the 
degradation of β -catenin in both the nucleus and cytoplasm in chicken PGCs. (D) JW74 treatment caused 
downregulation of cell cycle-related genes essential for entry in G1 phase (CCND1 and CDK6) and germ cell-
specific genes (cDAZL and CVH), but no effect on cell cycle-related genes regulating progression from G1 to S 
phase (CCNE1 and CDK2) as confirmed by qRT-PCR. Values in (B) and (D) represent mean ± standard error of 
the mean (SEM) of triplicate analyses. *P < 0.05, **P < 0.01, and ***P < 0.001. n.s.; not significant.
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8 of culture, and GFP expression was observed (Fig. 3A,B). The results showed that, in the experimental sets with 
bFGF, WNT1, WNT3A, BIO, WNT3A with bFGF, and BIO with bFGF, cell number had significantly increased at 
day 8 compared to that in culture without a growth factor, in which GFP-expressing PGCs were finally lost after 
10 days of culture. In the WNT9B group, an intermediate effect was shown. This indicates that β -catenin as well 
as bFGF can activate chicken PGCs to proliferate in vitro (Fig. 3A,B). On the other hand, JW74-treated PGCs 
did not grow, as the group without any growth factor showed the same pattern. In the group treated with JW74 
supplemented with bFGF, this treatment could not rescue the inhibition of cell growth (Fig. 3A,B).
Β-catenin-mediated activation of chicken PGCs through bFGF. Since bFGF is one of the key factors 
that enable the proliferation of chicken PGCs via MEK/ERK signaling24, we assumed that β -catenin is a down-
stream gene of bFGF in PGCs. To prove this, we used immunostaining to confirm the translocation of β -catenin 
into the nucleus from the cytoplasm (Fig. 4). After JW74 treatment (10 μ M) for 2 days, most β -catenin in both the 
nucleus and cytoplasm had been degraded and was only detected in the membrane (Fig. 4A). When β -catenin 
had been almost completely cleared from the nucleus and cytoplasm, bFGF was added for 8 h. As a result, the 
translocation of β -catenin into the nucleus significantly increased (Fig. 4A,B), indicating that bFGF can activate 
and stabilize β -catenin to promote the proliferation of chicken PGCs.
Discussion
Compared to other somatic cells, primordial germ cells have unique spatial and temporal developmental char-
acteristics1, and several signaling pathways play important roles in regulating their development2. Among them, 
Wnt signaling has also been shown to be involved in PGC development in several model animals16,40,41, but not yet 
in chicken. In this study, based on the expression of Wnt signaling-related genes in chicken PGCs, we suggested 
that the Wnt pathway might play an important role in PGCs in chicken. Most Wnt signaling pathway-related 
genes were upregulated in cultured PGCs compared to those in gonadal PGCs, indicating that Wnt signaling 
might be more activated in these specific conditions, in vitro, to facilitate proliferation. In addition, β -catenin, an 
important mediator of Wnt signaling, was stabilized in cultured PGCs considering their localization in both the 
nucleus and the cytoplasm. These results suggest that chicken PGCs can activate and process the Wnt signaling 
pathway.
Figure 3. The effects of BIO and JW74 on the proliferation of cultured chicken PGCs (SNUhp26). 
Proliferation assay was performed with SNUhp26 PGCs, expressing green fluorescent protein (GFP). After 
bFGF starvation for 4 days, a single PGC was added to each medium containing bFGF, WNT1, WNT3A, 
WNT9B, BIO, or JW74 with or without bFGF, and cultured for 8 days. (A) The number of PGCs in each 
treatment was counted after 8 days. Values represent mean ± SEM of triplicate analyses. Values with different 
letters are significantly different (P < 0.05). (B) The GFP-expressing PGCs after each treatment were observed 
under a fluorescence microscope.
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Aberrant activation of the canonical Wnt/β -catenin pathway is one of the most common signaling abnormal-
ities in human and mouse cancer42,43, because it activates numerous genes related to cell cycle progression. To 
investigate the role of the Wnt/β -catenin pathway in chicken PGCs, we used BIO and JW74, well-known inhibi-
tors of GSK3β and β -catenin, respectively17,18. We confirmed that both BIO and JW74, respectively, could activate 
and inactivate β -catenin in cultured PGCs by modulating the level of its active form (ABC). When β -catenin is 
activated and stabilized in the cytoplasm, it is transported into the nucleus, leading to formation of a transcrip-
tional complex with the TCF transcription factor44. Specific gene expression mediated by β -catenin activation 
generally occurs in a cell-context and cell-dependent manner. Cyclin D1, MYC, and cJun are the best-known 
target genes that enhance proliferation45. In this study, to investigate the role of Wnt/β -catenin signaling, 
loss-of-function studies were conducted by applying JW74. The results suggest that inhibition of Wnt/β -catenin 
signaling induces cell cycle arrest by downregulation of CCND1 and CDK646, revealing that Wnt/β -catenin sign-
aling is required for the maintenance of PGC proliferation.
Next, to test whether Wnt/β -catenin is involved in the proliferation of chicken PGCs, we activated the Wnt 
signaling pathway in PGCs using Wnt ligands or the activation of a component downstream of it, β -catenin, using 
BIO. The results of our proliferation assay suggested that the activation of Wnt/β -catenin signaling induced the 
proliferation of PGCs in vitro, while JW74 treatment prevented this. Also, the proliferative ability induced by 
the activation of Wnt/β -catenin signaling was similar as those induced by bFGF, which is known as a major pro-
liferation inducer in chicken PGCs23–25. These results suggest that Wnt/β -catenin signaling is required for PGC 
proliferation in vitro.
Our proliferation assay confirmed two other findings. First, no synergistic effect was observed upon the treat-
ment of Wnt ligands or BIO in combination with bFGF, suggesting that bFGF and Wnt do not act independently 
of each other, and that PGCs already reach the threshold of proliferation capacity in the presence of either bFGF 
or Wnt alone. Second, bFGF treatment could not rescue PGC proliferation in the presence of JW74 (in the 
absence of Wnt/β -catenin signaling), indicating that bFGF helps PGCs to proliferate through direct activation 
of the downstream Wnt/β -catenin signaling pathway. Previous studies on the crosstalk between β -catenin and 
bFGF support our results. For example, in the absence of bFGF, β -catenin is only located in the membrane with 
E-cadherin, whereas it accumulates and is stably translocated into the nucleus to activate downstream genes in 
the presence of bFGF14,27. In the presence of bFGF, β -catenin helps neural stem cells proliferate when it is overex-
pressed, while enhancing neuronal differentiation in the absence of bFGF28. Moreover, bFGF increases β -catenin 
signaling in neural progenitor cells via multiple mechanisms: increasing the level of β -catenin mRNA, nuclear 
translocation of β -catenin, and phosphorylation of GSK-3β 47. Because the role of β -catenin in the proliferation 
of chicken PGCs was recently reported48, in this study, we focused on evaluating the crosstalk between bFGF and 
β -catenin in chicken PGCs. First, we applied JW74 for the degradation of β -catenin and then added bFGF to the 
culture medium. Our results showed the reactivation of β -catenin by bFGF treatment after JW74. These results 
suggest that bFGF signaling promotes the proliferation of chicken PGCs via the activation of β -catenin and its 
downstream signaling. Many studies have shown that β -catenin is a target gene of FGF signaling through RAS/
ERK or PI3K/AKT cascades27–30. Therefore, it is worthwhile studying which downstream signals are involved in 
their crosstalk in PGCs.
Figure 4. Activation and stabilization of β-catenin by bFGF treatment of chicken PGCs (SNUhp26).  
(A) Immunostaining for β -catenin showed that the JW74 treatment caused the degradation of β -catenin in both 
the nucleus and the cytoplasm in cultured chicken PGCs. When bFGF was added followed by JW74 treatment, 
β -catenin translocated into the nucleus from the membrane. (B) The relative number of PGCs with β -catenin 
located in the nucleus was counted after each treatment. *P < 0.05. n.s.; not significant.
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In our study, the role of the Wnt/β -catenin signaling pathway was investigated for the first time in chicken 
PGCs, and the relationship between Wnt/β -catenin and bFGF was revealed. We concluded that Wnt/β -catenin 
can enhance the proliferation of chicken PGCs, and act as a factor downstream of bFGF signaling. Interestingly, 
in mouse, Wnt/β -catenin signaling is suppressed and deleterious for PGC proliferation8. Thus, our results suggest 
that, although many key signaling pathways for PGC development are conserved among animal species, the spe-
cific mechanism of regulation could differ. In addition, the recent report suggests the requirement of combinato-
rial action of different signals on PGC self-renewal26. Thus, a following study could be investigation on epistasis 
and crosstalk among different signaling pathways, such as TGF beta, FGF, Insulin, and WNT on PGC prolifer-
ation. Taken together, this research should contribute to studies on PGC biology and provide a comprehensive 
understanding of the mechanism behind PGC development from an evo-devo perspective.
Methods
Experimental animals and animal care. The care and experimental use of chickens were approved by 
the Institute of Laboratory Animal Resources, Seoul National University (SNU-150827-1). The chickens were 
maintained in accordance with a standard management program at the University Animal Farm, Seoul National 
University, South Korea. The procedures for animal management, reproduction, and embryo manipulation 
adhered to the standard operating protocols of our laboratory.
PGC isolation and culture. To conduct gene expression analysis, PGCs from White Leghorn embry-
onic gonads at day 6 (stage 28) were isolated by magnetic activated cell sorting as previously reported49. 
Anti-stage-specific embryonic antigen (SSEA)-1 antibody-positive cells were regarded as gonadal PGCs, 
while anti-SSEA-1 antibody-negative cells were regarded as gonadal stromal cells (GSCs). For in vitro culture, 
SNUhp26 male line cultured PGCs50, expressing green fluorescent protein (GFP), were maintained with knock-
out Dulbecco’s Modified Eagle Medium (Thermo Fisher–Invitrogen, Carlsbad, CA, USA) supplemented with 
20% (vol/vol) fetal bovine serum (Invitrogen), 2% (vol/vol) chicken serum (Sigma-Aldrich, St. Louis, MO, 
USA), 1× nucleosides (Millipore, Temecula, CA, USA), 2 mM L-glutamine, 1× nonessential amino acids, 
β -mercaptoethanol, 10 mM sodium pyruvate, and 1× antibiotic–antimycotic (Invitrogen). Human bFGF (Koma 
Biotech, Seoul, South Korea) was used at 10 ng/mL for PGC self-renewal. Chicken PGCs were cultured in an incu-
bator maintained at 37 °C with an atmosphere of 5% CO2 and 60–70% relative humidity. The cultured PGCs were 
subcultured onto mitomycin-inactivated murine embryonic fibroblasts in 5 to 6-day intervals by gentle pipetting 
without any enzyme treatment.
RT-PCR and qRT-PCR analyses. Total RNA was extracted from each sample with Trizol reagent 
(Invitrogen), in accordance with the manufacturer’s protocol. The RNA quantity was determined by spectropho-
tometry at 260 nm, and 1 μ g of each RNA sample was reverse-transcribed with the Superscript III First-Strand 
Synthesis System (Invitrogen). The cDNA was diluted five-fold and quantitatively equalized for PCR amplifica-
tion. RT-PCR was conducted to examine the change in expression of candidate genes in cultured chicken PGCs 
using specific primer sets (Table 1). PCR amplification was performed as follows: 94 °C for 5 min, followed by 
26–32 cycles at 94 °C for 30 s, 58–62 °C for 30 s, and 72 °C for 30 s. The PCR products were mixed with SYBR® Safe 
(Invitrogen) and loaded for gel electrophoresis. Confirmation of the results was performed using the ChemiDoc 
XRS System (Bio-Rad Laboratories, Hercules, CA, USA). Downregulation of cell cycle- or germ cell-related genes 
at the mRNA level was analyzed using quantitative RT-PCR (qRT-PCR). Relative expression was calculated after 
the threshold cycle had been normalized to that of chicken glyceraldehyde 3-phosphate dehydrogenase.
Western blot analysis. Total protein was extracted with the CytoBusterTM Protein Extraction Reagent 
(Novagen, Darmstadt, Germany), separated on a 10% polyacrylamide gel, and transferred to a polyvinylidene flu-
oride membrane (Millipore). The primary antibodies were mouse anti-β -actin (Santa Cruz Biotechnology, Santa 
Cruz, CA, USA) and rabbit anti-non-phospho (Active) β -catenin (Ser33/37.Thr41) (Cell Signaling, Danvers, MA, 
USA). Horseradish peroxidase-conjugated anti-mouse IgG and anti-rabbit IgG (Santa Cruz) were used as the sec-
ondary antibodies. The blots were treated with the enhanced chemiluminescence substrate solutions and exposed 
to a ChemiDoc XRS System (Bio-Rad) to detect chemiluminescence.
Proliferation assay by single-cell pick-up. SNUhp26 male line cultured PGCs, expressing GFP, were 
used for evaluating the rate of proliferation50. The SNUhp26 has a full germ cell characteristics and potency that 
can produce germline chimera and its progeny50. A total of 10 culture conditions were prepared in 96-well plates 
as follows: no growth factor (w/o GF), bFGF (10 ng/mL), WNT1 (100 ng/mL; Abcam, Cambridge, UK), WNT3A 
(100 ng/mL; Cell Signaling), WNT9B (400 ng/mL; R&D Systems, Minneapolis, MN, USA), BIO (Sigma; B1686), 
JW74 (Sigma; SML0227), WNT3A with bFGF, BIO with bFGF, and JW74 with bFGF. After 4 days of bFGF star-
vation, a single PGC was picked up and added to culture under each of the above conditions. The final concentra-
tions of BIO and JW74 were 1 and 10 μ M, respectively. After 8 days of culture, the number of PGCs was counted 
by fluorescence microscopy.
Immunocytochemistry. Cells were moved from the culture plate and dried on HistoBond® adhesive micro-
scope slides (Marienfeld-Superior, Lauda-Königshofen, Germany) for approximately 30 min. Then they were 
fixed in 100% methanol and prechilled for 3 min at − 20 °C. After washing the cells three times for 10 min each in 
phosphate-buffered saline containing 1% normal goat serum, they were incubated in diluted anti-β -catenin anti-
body (mouse IgG) or anti-SSEA-1 (mouse IgM) antibody as a primary antibody at 4 °C for 24 h, and then incu-
bated again in diluted Alexa-IgG-568 antibody or fluorescein isothiocyanate (FITC; Santa Cruz)-conjugated goat 
anti-mouse IgM, respectively, as a secondary antibody for 1 h at room temperature. Samples were then mounted 
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with Prolong Gold antifade reagent with 4′ ,6-diamidino-2-phenylindole (Invitrogen) and visualized using fluo-
rescence microscopy.
Statistical analysis. Statistical analysis was performed using SAS version 9.4 software (SAS Institute, Cary, 
NC, USA). When a significant main effect was detected by analysis of variance using SAS, the least-squares analy-
sis was used to compare the different treatments. Differences between control and treatment groups were deemed 
to be significant when P < 0.05.
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Gene name Description Accession No.
Primer Sequences (5′ → 3′)
Forward Reverse
cDAZL deleted in azoospermia ̶ like NM_204218.1 CTCCTGCACCGCAATTCCAT TCTTTGCTCCCCAGGAACCC
cVASA DEAD (Asp ̶ Glu ̶ Ala ̶ Asp) box polypeptide 4 NM_204708.1 CCGCATGCTCGATATGGGTT TCCCTCTTGGATAACCGGGG
WNT1 wingless ̶ type MMTV integration site family, member 1 XM_015273182.1 TCTCAGGGCCCCAACATCTT CGAAGAGCCTCCCGAAATCG
WNT3A wingless ̶ type MMTV integration site family, member 3A NM_001171601.1 AGGCCCTTTGTGGTGGGAGT GAGGGGGTGAAGTTGGGCAT
WNT9B wingless ̶ type MMTV integration site family, member 9B XM_015299263.1 GCTTTCGCCTTTCCACGAGA CACGTTCTCCCAGCAGTTCC
FZD1 frizzled family receptor 1 NM_001030337.1 CTGCTTCGTGGGCATCAACA AATGACGATGGTGGCCGGTA
FZD3 frizzled family receptor 3 NM_001271940.1 GGCTTTTTGTCACCCCTCCC AATGTGCCCAGGTCACCCAG
LRP5 low density lipoprotein receptor ̶ related protein 5 NM_001012897.1 GCAAGAGCGAGCTCCCAAGA AGGCCCATTGGCTGAAGGAT
LRP6 low density lipoprotein receptor ̶ related protein 6 XM_417286.4 CTGTATGCAAACCGCCGTGA ATGCCAGCCCATCAGGTGAC
ß ̶ catenin catenin (cadherin ̶ associated protein), beta 1, 88k NM_205081.1 ATTTGTGCGCTCCGTCACCT ACCTTGTTCACGCAGTGGGG
GSK3ß glycogen synthase kinase 3 XM_416557.4 TCCATTCCTTTGGGATCTGCC TACACAGCCCGCTGACCACA
TCF1 (TCF7) transcription factor 7 (T ̶ cell specific, HMG ̶ box) NM_204547.1 ATGAAAGAGATGCGGGCGAA CTGCTGCTTTTCCCGTGTCC
LEF1 lymphoid enhancer ̶ binding factor 1 NM_205013.2 GCGGCTTGTACAGCAAGGGA GGAGCCTGGGGAAAAGTGCT
TCF3 (TCF7L1) transcription factor 7 ̶ like 1 (T ̶ cell specific, HMG ̶ box) XM_003643906.2 GGAATGCTGATGTGGGACCG CCCAAACTGTGGGACCGAAA
TCF4 (TCF7L2) transcription factor 7 ̶ like 2 (T ̶ cell specific, HMG ̶ box) NM_001206510.2 AAATCCCCCATCCGCTAGGA AGCCGACGTCACTCTGGGAA
CDK6 cyclin-dependent kinase 6 NM_001007892.2 TGGGGCTGCTTCACATTGAC GCCAGCAGCAAAACGTTCAG
CCND1 cyclin D1 NM_205381.1 GGTGCTGCAGACCATGCTGA GCAATTGCAACCGGCTTTTC
CDK2 cyclin-dependent kinase 2 NM_001199857.1 GAGCTACCTGTTCCAGCTGC CCAGATGTCCACAGCAGTCG
CCNE1 cyclin E1 NM_001031358.1 TCGAGTACGCCAGCCACTTA GAAATGTCGCCTTGCACAGC
GAPDH glyceraldehyde ̶ 3 ̶ phosphate dehydrogenase NM_204305.1 GGTGGTGCTAAGCGTGTTAT ACCTCTGTCATCTCTCCACA
Table 1.  Primers used for RT-PCR.
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